AscopiaveASC
ASC logo
Fair Value
€3.8
Share price17 Jun
€2.8824.2% undervalued intrinsic discount
Loading
1Y-9.29%
7D-4.00%

Wind Farm Projects And EstEnergy Stake Sale Will Improve Future Prospects

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
09 Mar 25
Updated
17 Jun 26
Views
33
Not Invested

Last Update 17 Jun 26

ASC: Stable Assumptions And Steady Dividend Will Support Future Upside

Analysts have left their fair value estimate for Ascopiave unchanged at €3.80. They cite only minor tweaks to discount rate, revenue growth and profit margin assumptions that do not materially alter their overall price target view.

What’s in the News for Ascopiave

  • No recent company specific news items for Ascopiave are available from the provided primary or secondary sources as of 16 Jun 2026.
  • Investors following Ascopiave currently need to rely mainly on valuation updates and existing public filings, given the absence of new reported events in the supplied feeds.
  • The unchanged fair value estimate of €3.80 reflects the latest available analyst work, in the context of limited fresh news flow on Ascopiave.

Valuation Changes

  • Fair Value is unchanged at €3.80 per share, indicating no revision to the central valuation level for Ascopiave.
  • The Discount Rate has been adjusted slightly from 8.76% to 8.69%, a small reduction in the rate used to discount projected cash flows.
  • Revenue Growth is retained at 5.49% with only a rounding level change, so the growth assumption is effectively stable.
  • The Net Profit Margin is held at about 14.84% with a minimal technical adjustment, implying no practical change in profitability assumptions.
  • The Future P/E has moved marginally from 23.27x to 23.23x, a very small shift in the valuation multiple applied to Ascopiave earnings.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Strategic restructuring and simplification may enhance operational efficiencies and net margins through mergers and acquisitions, particularly in renewable energy and gas distribution.
  • Asset divestitures and strategic partnerships are expected to provide financial inflow, supporting future revenue growth and capital expenditures.
  • Rising interest rates and variable-rate debt exposure could decrease profitability, while strategic M&A focus might limit market expansion and long-term growth.

Catalysts

About Ascopiave
    Engages in the distribution of natural gas in Italy.
What are the underlying business or industry changes driving this perspective?
  • The strategic reorganization and simplification of the company's corporate structure have streamlined operations and might lead to improved operational efficiencies, potentially boosting net margins.
  • The completion of mergers and acquisitions in the renewable energy sector, including the development of new wind farms, is expected to increase renewable energy production, thus contributing to future revenue growth.
  • The sale of a 25% shareholding in EstEnergy scheduled for completion by July 2025 is likely to generate significant cash inflow and positively impact the net financial position, potentially improving earnings.
  • Ongoing focus on mergers and acquisitions in the Northern region, aiming for growth in the gas distribution field, suggests potential scale advantages that could enhance operational margin efficiency and revenue.
  • The expected proceeds and financial optimization from strategic partnerships and asset divestitures (e.g., with Hera, and future funding via bank loans and stock placement), could support capital expenditures and further drive future earnings growth.
Ascopiave Earnings and Revenue Growth

Ascopiave Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ascopiave's revenue will grow by 5.5% annually over the next 3 years.
  • Analysts assume that profit margins will shrink from 32.7% today to 14.8% in 3 years time.
  • Analysts expect earnings to reach €45.4 million (and earnings per share of €0.21) by about June 2029, down from €85.0 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 23.3x on those 2029 earnings, up from 7.6x today. This future PE is greater than the current PE for the GB Gas Utilities industry at 18.0x.
  • Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.69%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Rising interest rates have increased financial expenses by €2.3 million, which could continue to negatively impact net margins and earnings if rates remain high or increase further.
  • Net financial position with a significant proportion of debt (59%) being variable-rate exposes the company to fluctuations in interest rates, potentially increasing financial costs and decreasing profitability.
  • The company's decision to focus on merger and acquisition activities within specific regions, while potentially beneficial for operational efficiency, may limit market expansion opportunities, impacting long-term revenue growth prospects.
  • An increase in the tax rate from 30.2% to 34.5% as of December 2024 could significantly reduce net income and negatively affect earnings.
  • Unpredictability in tariff revenue changes, which the company admitted were unexpected, could lead to future revenue volatility and impact financial stability negatively if not managed effectively.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €3.8 for Ascopiave based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €305.6 million, earnings will come to €45.4 million, and it would be trading on a PE ratio of 23.3x, assuming you use a discount rate of 8.7%.
  • Given the current share price of €2.98, the analyst price target of €3.8 is 21.6% higher. Despite analysts expecting the underlying business to decline, they seem to believe it's more valuable than what the market thinks.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ascopiave?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

€3.8
vs €2.8824.2% undervalued intrinsic discount
PastFuture0570m2015201820212024202620272029Revenue €305.6mEarnings €45.4m
5.5%
Revenue growth
14.8%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Ascopiave

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Solid track record established dividend payer.

Market cap€626.6m
PB0.7x
Estimated Growth4.9%
Dividend Yield5.6%
Full analysis

CEO & management

Stefano Fae
CEO
1.3yrs
CEO Tenure

Engages in the distribution of natural gas in Italy.